Refresher on RVNC phase-2 CD* data that triggered the decision to advance the CD program to phase-3: #msg-131479120 #msg-131924083 11/29/17 press release (for archival purposes): http://investors.revance.com/releasedetail.cfm?ReleaseID=1050212 *Cervical dystonia.